drugset / Trial / NCT03046238

Efficacy and Safety of Dexmedetomidine Added to Modified Pectoral's Block in Breast Cancer Patients

NCT03046238

Phase 3 Unknown 60 enrolled South Egypt Cancer Institute
RandomizedParallel-groupTriple-blindHealth-services research

Summary

To Evaluate the effect of addition of Dexmedetomedine to ultrasound guided modified Pecs block on post operative analgesia \& stress response in patient undergoing modified radical mastectomy.

Timeline

Start
2017-02-02
Primary completion
2017-04-02
Completion
2017-04-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 1 ug/kg Other

Indications